Practice
Buy-Side & Diligence Support
Sharper diligence and better decisions for PE deal teams, with a former ExCom and General Counsel industry perspective on material risks, value drivers and execution certainty.
Sharper diligence. Better decisions.
Supporting PE deal teams and external counsel with a former ExCom and General Counsel industry perspective focused on material risks, value drivers and execution certainty.
Areas of Support
- Buy-side legal diligence support
- DD coordination, issue prioritization and Q&A strategy
- Expert sessions with management and functional leaders
- Review of key value drivers and legal downside risks
- Pharma-specific review of licensing, supply, distribution, sanctions, HCP/HCO and regulatory topics
- Review of governance, compliance and risk management maturity
- Distinction between red flags, non-issues and post-closing clean-up items
- Translation of legal, compliance, and IP findings into IC-relevant input
- Structuring of post-closing clean-up roadmap for DD findings
- Early view on exit implications of identified issues
Focus
- Identifying what truly matters to assess the target.
- Avoiding legal noise.